NephroPlus
General
Deals Digest: Funding value remains buoyant due to large fintech PE deal
Dealmaking activity by private equity and venture capital firms dipped marginally this week but stayed above the $500-million mark as ......
General
Grapevine: Quadria Capital sets sight on PE-backed dialysis chain; WizFreight raises funding
Asia healthcare-focussed private equity firm Quadria Capital, which has backed names like Maxivision Eye Hospitals, MediBuddy, Nobel Hygiene and Concord ......
Finance
NephroPlus looks to buy up to 7 companies, plans listing this FY
NephroPlus is in discussions to acquire 6-7 mid-sized companies, mainly in India and the Philippines, even as the dialysis chain ......
Healthcare
NephroPlus aims to go public in 2 years
Top dialysis chain NephroPlus plans to launch its initial public offering (IPO) in the next two years and is currently ......
Finance
Investcorp may launch second India-focused $400 mn fund in early 2022
Bahrain-based Investcorp is planning to launch a second India-focused fund early next year, even as it is sharpening its focus on real estate ......
Finance
Investcorp wants to bet big on global businesses built in India
After snapping up ecommerce solutions provider Unilog last month, mid-market private equity investor Investcorp is priming for multiple deals in ......
Healthcare
Investcorp-backed NephroPlus makes first overseas acquisition
Dialysis chain NephroPlus, which is backed by Bahrain-based private equity firm Investcorp, said Tuesday it has bought a majority stake ......
Finance
Venture debt firm Trifecta invests in student lender
Venture debt provider Trifecta Capital has placed its latest bet on a lender that caters to students, a person privy ......
Healthcare
European investor-backed dialysis chain 7Med in talks for Series B funding
Dialysis clinic chain 7Med India Pvt. Ltd, which had received investment from a European company two years ago, is looking ......
Healthcare
Flashback 2019: Single-specialty, regional hospitals steal the thunder in healthcare
A strong revival of investor interest in eye-care clinics, big-ticket deals in the dialysis, fertility and oncology segments and a ......
